07-Jun-2021 | Facts and Factors
According to Facts and Factors' most recent research and survey study, the global diabetic foot ulcer treatment market was valued at over USD 8.7 billion in 2020 and is predicted to reach USD 12.3 billion by 2026, rising at a remarkable 7.9% CAGR between 2021 and 2026.
Diabetic foot ulcers are a medical disorder that presents the patient with an open wound on the bottom of the foot. Patients suffering from diabetic conditions are often presented with this alternative disorder due to peripheral neuropathy and ischemia from peripheral vascular diseases. The major driving forces behind the significant growth of the diabetic foot ulcer treatment market are a rise in diabetic conditions among the aging population and a rise in the geriatric population. Other factors include widened medical infrastructure and extensive R&D in the sector.
Additionally, the other factors boosting the growth of the market during the forecast are the rise in the adoption of alternative treatment options such as novel therapeutics, improved biologics, and improved prioritization of treatment instead of surgical procedures. A sedentary lifestyle, advanced aging population, and increased patient awareness will augment the growth of the diabetic foot ulcer treatment market during the forecast timeframe.
Report Scope
Report Attribute |
Details |
Market Size in 2020 |
USD 8.7 Billion |
Projected Market Size in 2026 |
USD 12.3 Billion |
CAGR Growth Rate |
7.9% CAGR |
Base Year |
2020 |
Forecast Years |
2021-2026 |
Key Market Players |
3M Healthcare, Coloplast A/S, Smith & Nephew Plc., B. Braun Melsungen AG, Molnlycke Health Care AB, BSN Medical GMBH, Integra LifeSciences Corporation, Cardinal Health., and Others |
Key Segment |
By Type of Treatment, Type of Ulcers, End-User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Top Market Players
The key participants in the global diabetic foot ulcer treatment market are 3M Healthcare, Coloplast A/S, Smith & Nephew Plc., B. Braun Melsungen AG, Molnlycke Health Care AB, BSN Medical GMBH, Integra LifeSciences Corporation, and Cardinal Health., among others.
Market Dynamics
The latest market developments in the diabetic foot ulcer treatment options are noted down below –
- Molnlycke partnered with German wound care firm SastoMed GnbH in order to expand their product offering to combine patient care with a wider range of disorders related to wound healing procedures and chronic wound treatment.
- UPM launched a new advanced wound care product in Europe that can create wood-based nanofibrillar cellulose with regulatory approval.
- SANUWAVE Health, Inc., received their FDA approval for their product Dermapace System, a shockwave-based device intended to treat diabetic foot ulcers.
On the basis of types of treatment, the global diabetic foot ulcer treatment market can be divided into wound care dressings, biologics, therapy devices, antibiotics medications, and others. The wound care segment can be further categorized into alginate dressings, hydrofiber dressings, foam & film dressings, surgical dressings, and hydrocolloid dressings. The wound care category will occupy the largest market share during the forecast period owing to increased research and developmental spending by key players and the adoption of alternative medical options. The surge in the per capita income in the healthcare expenditure, advancement in the treatment technologies, and rising awareness about these treatments in the emerging technologies are other factors likely to boom the market growth during the forecast period. The rise in demand for extracorporeal shock wave therapy and negative pressure wound therapy further propel the wound care dressing category. The easy exudate management, low healing time, and low wound care cost are supplementary factors anticipated to fuel the global diabetic foot ulcer treatment market.
Based on the types of ulcers, the market is classified into neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers. From which, the neuro-ischemic ulcers hold the largest market share in the global diabetic foot ulcer treatment market. The dominance is primarily due to the high treatment costs and the rising prevalence of this type of ulcer.
On the basis of end-users, the global diabetic foot ulcer treatment market can be divided into hospitals, long-term care, specialty care, clinics, and ambulatory surgical centers. The hospital segment will account for the largest market share during the forecast owing to advanced medical protocols and established dominance of hospitals over treatment of diabetic foot ulcers. The favorable policies, access of advanced treatment options, and availability of skilled professionals are other factors augmenting the market growth.
North America Is Expected To Witness The Highest Market Growth During the Forecast
North America is expected to recoup the largest market share during the advent of the forecast and the region of Asia-Pacific is expected to witness the fastest growing CAGR. Factors pertaining to the rapid growth of the diabetic foot ulcer treatment market in North America contribute to the rapid technological developments and larger revenue streams being converted into R&D projects. Furthermore, the advanced medical infrastructure in the region and the presence of key players in the region will prove as the breeding ground for higher sales.
Browse the full “Diabetic Ulcer Foot Treatment Market By Type of Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotics Medications, and Others), By Type of Ulcers (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-Ischemic Ulcers), By End-User (Hospitals, Specialty Centers, Long Terms Care Centers, Clinics, & Ambulatory Surgical Clinics), And By Regions – Global & Regional Industry Perspective, Comprehensive Analysis, and Forecasts, 2021 – 2026” report at https://www.fnfresearch.com/diabetic-ulcer-foot-treatment-market.
The global diabetic foot ulcer treatment market can be segmented into:
Global Diabetic Foot Ulcer Treatment Market: By Type of Treatment Segment Analysis
- Wound Care Dressings
- Alginate Dressings
- Hydrofiber Dressings
- Foam & Film Dressings
- Surgical Dressings
- Hydrocolloid Dressings
- Biologics
- Growth Factors
- Skin Grafts
- Therapy Devices
- Negative Pressure Wound Therapy
- Ultrasound Therapy
- Antibiotics Medications
- Others
Global Diabetic Foot Ulcer Treatment Market: By Type of Ulcers Segment Analysis
- Neuropathic Ulcers
- Ischemic Ulcers
- Neuro-Ischemic Ulcers
Global Diabetic Foot Ulcer Treatment Market: By End-User Segment Analysis
- Hospitals
- Clinics
- Ambulatory Surgical Centers
Global Diabetic Foot Ulcer Treatment Market: By Regional Segment Analysis
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Brazil
- Mexico
- Rest of Latin America
- GCC Countries
- South Africa
- Rest of MEA
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
